Target intelligence / Profile preview

Hepatitis B virus antigen-presenting cell interaction (HBV-APC interaction)

Target
HBV-APC interaction
Molecular classification
MHC class I, MHC class II, T cell receptor, B cell receptor, Co-stimulatory molecules, Cytokines, Chemokines
01

Overview

The interaction between Hepatitis B virus (HBV) antigens and antigen-presenting cells (APCs) is central to the immune response against HBV infection. This process involves the recognition, processing, and presentation of viral antigens by APCs—primarily dendritic cells (DCs), macrophages, Kupffer cells, and B cells—to T lymphocytes. The efficiency and nature of these interactions determine whether HBV is cleared or persists chronically. Dysregulation of APC function in chronic HBV impairs effective T cell and B cell responses, leading to immune tolerance and viral persistence.

Other names
HBV antigen presentationHepatitis B antigen processingHBV-mediated immune activationHBV-APC cross-talk
02

Mechanism of action

Modulation of antigen presentation pathways to enhance T cell and B cell responses against HBV. Blockade of inhibitory signals and stimulation of co-stimulatory pathways.

03

Biological functions

Antigen processing and presentationT cell activationB cell activationAntibody productionCytokine productionImmune modulationImmune evasion
04

Disease associations

Hepatitis B infectionChronic hepatitis BLiver cirrhosisHepatocellular carcinomaImmune toleranceImmune exhaustion
05

Safety considerations

Cytokine stormAutoimmunityLiver inflammationOff-target effects on immune cells
06

Interacting drugs

Interferon alpha

4 more in the full profile.

07

Biomarkers

HBsAg levelsAnti-HBs antibody titersHBV DNA loadT cell subsets (CD4+, CD8+)Cytokine profiles (IL-12, IFN-alpha, IL-10)Expression of co-stimulatory molecules (CD80, CD86, CD40)MHC expression on APCs

Beyond the preview

Go deeper on Hepatitis B virus antigen-presenting cell interaction (HBV-APC interaction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus antigen-presenting cell interaction (HBV-APC interaction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call